Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use RESTASIS MULTIDOSE safely and effectively. See full prescribing information for RESTASIS MULTIDOSE . RESTASIS MULTIDOSE ® ( cyclosporine ophthalmic emulsion ) 0.05% , f or topical ophthalmic use Initial U.S. Approval: 1983
Medication labelWhy this: Advisory · dailymed-prescription
RESTASIS MULTIDOSE ® ophthalmic emulsion is indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca. Increased tear production was not seen in patients currently taking topical anti-inflammatory drugs or using punctal plugs.
- generic_name
- cyclosporine
- product_names
- cyclosporine
- ndc
- 0023-5301, 0023-5301-05, 0023-5301-08
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en